Mahmoud Y Madi

Delighted to have officially joined UT Austin, Division of Gastroenterology & Hepatology as a Clinical Assistant Professor. dellmed.utexas.edu/directory/mahm…

#mdpijcm 📢Check out #SystematicReview Citations 11👏 Is #EndoscopicUltrasound-Guided Hepaticogastrostomy Safe and Effective after Failed Endoscopic Retrograde Cholangiopancreatography? 👉mdpi.com/2854376 👥@AlsakarnehSaqr @DushDahiya @HemantGoyalMD @MediPharma_MDPI

The Impact of Cannabis Use in Gastroparesis: A Propensity-Matched Analysis of 41,374 Gastroparesis Patients Kilani, et al. 📕 doi.org/10.14309/ajg.0… @YasKL88 @DGonzalezMMD @DrDiabat @JKRuffles @MahMadi90 @ibsdoc @MLongMD @JasmohanBajaj

Proud to share our work published in the Red Journal. Excellent work team!

Officially GI Board Certified! #GITwitter #LiverTwitter #MedEd #ABIM

New pub🚨 Just published @APandT 🎯 EDS patients exhibit heightened risk for GI (GERD, IBS, constipation) comorbidities, highlighting the importance of multidisciplinary approaches for effective management. 📖 onlinelibrary.wiley.com/doi/10.1111/ap… #GITwitter #MedTwitter @MayoClinicGIHep

@OmarAlTaanii Congratulations Omar! Well deserved

Very excited to share that I will be pursuing my GI fellowship at @WashUMedGastro! Grateful every day for the incredible support from my family, friends, and mentors who made this possible. Looking forward to the journey ahead! 🎉 @AHNIMres @TKapetanos

Congratulations to @Jarshah4 and the rest of the team. @ThomasRMcCarty3 @YasKL88 @MahMadi90 👏

@DrDiabat @SLUgastro @washumedicine @MalekAyoubMD 🔥 🔥 congratulations team!

Excited to share our latest study in BMJ Open on the relationship between MASLD/MASH and the risk of colorectal cancer and benign colorectal neoplasms 💥💥 Thanks to the stellar team @SLUgastro @washumedicine & @MahMadi90 @MalekAyoubMD 🌟👏🏼 bmjopen.bmj.com/content/15/11/…

🚨New Publication! "The Impact Of Opioid Use In Chronic Pancreatitis From 2004-2024: A Propensity-Matched Analysis Of 183,214 Individuals" Opioid use in CP is associated with: ⬆️Acute-on-chronic pancreatitis (aHR 1.45) ⬆️All-cause mortality (aHR 1.90) ⬆️Healthcare resource utilization 🔗: sciencedirect.com/science/articl… Grateful to our exceptional team and mentors: @MahMadi90 @ibsdoc @AsbjornDrewes #DrOlesen @TarekNammour @DGonzalezMMD @Ayah__Obeid #GITwitter #MedTwitter @SLUgastro @slusom

@AbuassiMoe @EndoAthlete @AlmomaniMD @DrHSKalsi @AmCollegeGastro @Bashar_Qumseya @essilfiequaye @AlsakarnehSaqr @yessthapa767 Excellent work as always 🔥

An amazing week at #ACG2025 ! presented multiple posters and was honored to receive the Presidential Poster Award for our study on EUS timing and treatment initiation for pancreatic lesions! So grateful for my mentors and co-authors 🙌 #MedTwitter #GITwitter

@Abdellatif_07_ @MSAbusuliman @khalidaloum @AbbarhShahem Congrats Abdellatif! Great work

More evidence supporting carvedilol as the beta blocker of choice for secondary EVH prophylaxis. Even better, carvedilol use was also associated with lower risk of further decompensation events in this population. Check out our new study here: link.springer.com/article/10.100…

@Anas_Al_Mardini @AbuassiMoe @EndoAthlete @AmCollegeGastro @AmerGastroAssn Congratulations! Amazing work as usual Mohammad

@AbuassiMoe @MahMadi90 @EndoAthlete @AmCollegeGastro @AmerGastroAssn Great work Dr Abuassi

Our abstract on real-world variation in time to EUS for pancreatic lesions was selected as a Presidential Poster recipient at #ACG2025 !✨⚕️ Grateful to my mentors and collaborators for their guidance!

Our latest publication 🚨 "The Impact of MASLD on Autoimmune Hepatitis Outcomes: A Nationwide Analysis of 2880 Records" In AIH patients, MASLD was linked to: ⬇️ 1-yr immunosuppressant use (HR 0.69) ⬆️ 10-yr risk of cirrhosis (HR 1.22) ⬆️ 10-yr risk of HCC (HR 2.03) 👉 Early detection & management of MASLD in patients with AIH is key. 🔗journals.lww.com/ctg/abstract/9… Thanks to our amazing team @DrDiabat @kymyves @BaselNaser89 @MahMadi90 #DrSyn #LiverTwitter #GITwitter #Hepatology @SLUgastro @slusom

📝🚨 New Publication Alert: TLDR - Despite progress 📉, thousands still get surgery for benign polyps. We’re not quite out of the OR yet. Link: link.springer.com/10.1007/s10620…

@YasKL88 Congratulations Yassine & team for this excellent work!

Our latest publication 🚨 "Trends in Surgical and Endoscopic Resection Intervention for Non-Malignant Colorectal Polyps over the Last Decade: A Nationwide Analysis" 📉 Surgery for non-malignant colorectal polyps is modestly declining (2014–2024) as EMR & ESD increase, yet avoidable surgeries persist—underscoring the need for better polyp characterization, broader access to expert endoscopists, and standardized quality metrics. 🔗: link.springer.com/10.1007/s10620… Thanks to our amazing team @MahMadi90 @DGonzalezMMD @AhmadBazarbashi @ThomasRMcCarty3 @Jarshah4 #GITwitter #MedTwitter #endoscopy #colorectalcancer

@Shahryarkhan163 Thanks Shahryar! Hope to see you soon 😄

@MahMadi90 Best of luck Madi.

Delighted to have officially joined UT Austin, Division of Gastroenterology & Hepatology as a Clinical Assistant Professor. dellmed.utexas.edu/directory/mahm…